Since we traditionally recognize that TGF-β1 and the accumulation of ECM contribute to the deterioration of renal function, our study suggests that inhibiting PERK during ER stress might constitute a potential novel therapy for improving DKD. The gene discussed is EIF2AK3; the disease is diabetic kidney disease.